Taking into consideration the relatively increasing abundance of the seven selected proteins across the grade groups, their increased levels in BCR+ compared to BCR- and the available research on their involvement in (prostate) cancer, it is suggested that the selected proteins are promising candidates for further investigation as potential PCa aggressiveness markers. The gene discussed is BCR; the disease is prostate cancer.